Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.1.02092
European Journal of Endocrinology, Vol 154, Issue 2, 303-309
Copyright © 2006 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jarfelt, M
Right arrow Articles by Bjarnason, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jarfelt, M
Right arrow Articles by Bjarnason, R

CLINICAL STUDY

Bone mineral density and bone turnover in young adult survivors of childhood acute lymphoblastic leukaemia

M Jarfelt1,2, H Fors2, B Lannering1 and R Bjarnason2,3

1 Department of Paediatrics, Division of Haematology and Oncology, 2 Göteborg Paediatric Growth Research Centre, Sahlgrenska Academy of Göteborg University, Göteborg, Sweden and 3 Department of Paediatrics, Landspitali University Hospital, Reykjavik, Iceland

(Correspondence should be addressed to M Jarfelt, Department of Paediatrics, The Queen Silvia Children’s Hospital, S-41685 Göteborg, Sweden; Email: marianne.jarfelt{at}vgregion.se)

Objective: Treatment for childhood leukaemia induces many risk factors for development of decreased bone mineral density (BMD). Physical activity is also known to affect BMD. The aim was to study BMD and markers of bone turnover in a well-defined group of survivors of acute lymphoblastic leukaemia (ALL) who had all reached final height as well as peak bone mass, taking both previous treatment and physical activity into consideration.

Design: All patients treated for ALL before the onset of puberty in the region of western Sweden, between 1973 and 1985, in first remission were included. Thirty-five out of forty-seven patients aged 20–32 years participated. Nineteen patients had received cranial radiotherapy, and the median follow-up time was 20 years.

Methods: BMD was assessed using dual-energy X-ray absorbtiometry (DEXA). Serum concentrations of markers of bone turnover were analysed. Physical performance was measured using a performance exercise capacity stress test.

Results: BMD was slightly reduced in lumbar spine (–0.4 SD), but not in femoral neck or total body. BMD in femoral neck was correlated to physical performance and dose of corticosteroid, but no correlation was found with spontaneous growth hormone (GH) secretion. Markers of bone turnover were also correlated to physical performance, but not to GH secretion.

Conclusions: Physical fitness seems to be the most important factor in developing and preserving normal bone mineral density in ALL patients. We propose that lifestyle education promoting physical activity is encouraged from an early point in time for these patients.




This article has been cited by other articles:


Home page
Journal of Pediatric Oncology NursingHome page
K. Ruble
Skeletal Complications After Bone Marrow Transplant in Childhood
Journal of Pediatric Oncology Nursing, April 1, 2008; 25(2): 79 - 85.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 European Society of Endocrinology.